Adenosine and Death - a phase IV clinical study of FDA data
Summary:
Death is reported as a side effect among people who take Adenosine (adenosine), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Heparin, and have High blood cholesterol.
The study is created by eHealthMe based on reports of 2,699 people who have side effects when taking Adenosine from the FDA, and is updated regularly.
What is Adenosine?
Adenosine has active ingredients of adenosine. eHealthMe is studying from 2,711 Adenosine users. Check the latest studies of Adenosine.
2,699 people reported to have side effects when taking Adenosine.
Among them, 23 people (0.85%) died.

Among these 23 people:
How long have people been on Adenosine when they died? *
- < 1 month: 50 %
- 1 - 6 months: 50 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who died when taking Adenosine? *
- female: 47.62 %
- male: 52.38 %
What is the age of people who died when taking Adenosine? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 5.56 %
- 60+: 94.44 %
What are other drugs people take besides Adenosine? *
- Heparin: 7 people, 30.43%
- Trasylol: 6 people, 26.09%
- Lasix: 5 people, 21.74%
- Norvasc: 4 people, 17.39%
- Plavix: 4 people, 17.39%
- Amlodipine: 4 people, 17.39%
- Protamine Sulfate: 4 people, 17.39%
- Nitroglycerin: 3 people, 13.04%
- Coumadin: 3 people, 13.04%
- Vitamin D3: 3 people, 13.04%
What are other side effects people have before they died? *
- Pain: 7 people, 30.43%
- Acute Kidney Failure: 7 people, 30.43%
- Stress And Anxiety: 7 people, 30.43%
- Anhedonia (inability to experience pleasure from activities usually found enjoyable): 6 people, 26.09%
- Injury: 6 people, 26.09%
- Fear: 5 people, 21.74%
- Renal Impairment (severely reduced kidney function): 4 people, 17.39%
- Emotional Distress: 4 people, 17.39%
- Multi-Organ Failure (multisystem organ failure): 3 people, 13.04%
- Renal Injury (kidney injury): 3 people, 13.04%
What are the existing conditions these people have? *
- Multiple Myeloma (cancer of the plasma cells): 2 people, 8.70%
- Pain: 2 people, 8.70%
- High Blood Cholesterol: 2 people, 8.70%
- Immunodeficiency Common Variable: 1 person, 4.35%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 1 person, 4.35%
- Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 4.35%
- Colon Cancer Metastatic (cancer of colon spreads to other part of body): 1 person, 4.35%
- Constipation: 1 person, 4.35%
- Coronary Revascularisation: 1 person, 4.35%
- Diabetes: 1 person, 4.35%
* Approximation only. Some reports may have incomplete information.
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Adenosine:
- Adenosine (2,711 reports)
Expand to all the drugs that have ingredients of adenosine:
- Death and drugs with ingredients of adenosine (32 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Adenosine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Death:
- Death (3,140 drugs)
Browse all the conditions that are associated with Death:
- Death (3,686 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on adenosine (the active ingredients of Adenosine) and Adenosine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Methamphetamine Hydrochloride vs. Depakote, side effect and effectiveness comparison - 2 seconds ago
- Could Tylenol cause Parainfluenzae Virus Infection? - 4 seconds ago
- Could Adenosine cause Hypotension? - 10 seconds ago
- Nasal Polyps and Nausea And Vomiting - 13 seconds ago
- Could Adderall cause Allergic Rhinitis? - 16 seconds ago
- Could Promethazine cause Hyperparathyroidism Secondary? - 18 seconds ago
- Could Torsemide cause Hoarseness Or Changing Voice? - 39 seconds ago
- Avandia vs. Humalog, side effect and effectiveness comparison - 39 seconds ago
- Drug interactions of Chlorpheniramine Maleate and Atorvastatin Calcium - 48 seconds ago
- Drug interactions of Chlorpheniramine Maleate and Quinine - 59 seconds ago